Based out of a leading teaching hospital, the CRDC fosters collaboration and innovation by connecting patients and families with:
- World-class experts
- Physician-scientists and researchers
- Pharmaceutical and industry partners
- Patient advocacy communities
Together, we strive to find new treatments, understand biological mechanisms, and discover the genetic causes of rare diseases using cutting-edge technologies.
CRDC is led by the Faculty Steering Committee (Drs. Piotr Sliz, Shira Rockowitz, Nancy Andrews, Alan Beggs, Mira Irons, Janet Chou) and works in close coordination with Dr. Wendy Chung and the Department of Pediatrics. CRDC collaborates with the International Child Health Partnership (IPCHiP) and is a member of the Global Alliance for Genomics and Health (GA4GH). CRDC is implemented by BCH Research Informatics and was established in 2018 in response to the recommendation from the BCH Genomic Blue Ribbon Committee.